Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globestar Therapeutics Corp (OP: GSTC )

0.0009 UNCHANGED
Streaming Delayed Price Updated: 2:53 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,911
Open 0.0008
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0009
Today's Range 0.0008 - 0.0009
52wk Range 0.0006 - 0.0063
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials
Via ACCESSWIRE
GlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis Treatment
Via ACCESSWIRE

Performance

YTD
-18.18%
-18.18%
1 Month
-43.75%
-43.75%
3 Month
N/A
N/A
6 Month
-57.14%
-57.14%
1 Year
-84.48%
-84.48%

More News

Read More
Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare to Manage Clinical Trial, Regulatory Filings, Manufacturing and Sales in MEA Region for Multiple Sclerosis Treatment
Via ACCESSWIRE
Transformative Therapies for Neurodegenerative Diseases; MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis: GlobeStar Therapeutics (Stock Symbol: GSTC)
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
Globestar Therapeutics Enters into MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
Via ACCESSWIRE
GlobeStar Therapeutics Corporation Update on Recent Activity
Via ACCESSWIRE
CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract
From GlobeStar Therapeutics Corporation
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract
From GlobeStar Therapeutics Corporation
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
GlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s Disease
From GlobeStar Therapeutics Corporation
Via AccessWire
GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets
From AngioSoma, Inc.
Via AccessWire
Exposures Product Safety
GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.
From GlobeStar Therapeutics Corporation
Via AccessWire
Exposures Product Safety
GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis
From AngioSoma, Inc.
Via AccessWire
Exposures Product Safety
GlobeStar Therapeutics Corporation Unveils New Corporate Website and Branding Campaign
From AngioSoma, Inc.
Via AccessWire
GlobeStar Therapeutics Corporation To Be Seen In The Washington Football Team Yearbook All Season
From AngioSoma, Inc.
Via AccessWire
AngioSoma, Inc. Is Officially GlobeStar Therapeutics Corporation.
From AngioSoma, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.